CFAP96 and pancreatic neoplasm: To test if C4orf47 expression has the potential to serve as a biomarker for pancreatic cancer prognosis, we evaluated the survival analysis for C4orf47 from The Human Protein Atlas using the investigation of C4orf47 mRNA expression.